User profiles for "author:Paolo Spagnolo"

Paolo Spagnolo

Istituto di Scienze Applicate e Sistemi Intelligenti - Consiglio Nazionale delle Ricerche
Verified email at cnr.it
Cited by 2103

Idiopathic pulmonary fibrosis: Disease mechanisms and drug development

P Spagnolo, JA Kropski, MG Jones, JS Lee… - Pharmacology & …, 2021 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease of unknown cause
characterized by relentless scarring of the lung parenchyma leading to reduced quality of life …

Corticosteroids for idiopathic pulmonary fibrosis

L Richeldi, HRHR Davies, P Spagnolo… - Cochrane database …, 1996 - cochranelibrary.com
Background Idiopathic pulmonary fibrosis (IPF) is a disease with significant morbidity and
mortality. Patients short survival time, high mortality and generally rapid decline raise the …

Pulmonary sarcoidosis

P Spagnolo, G Rossi, R Trisolini… - The Lancet …, 2018 - thelancet.com
Sarcoidosis is a granulomatous disease of unknown cause, occurs worldwide and has a
highly variable prevalence. The disease is typically dominant in the lungs, although it can …

[HTML][HTML] Pulmonary fibrosis secondary to COVID-19: a call to arms?

P Spagnolo, E Balestro, S Aliberti… - The Lancet …, 2020 - thelancet.com
As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000
people have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all …

Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

PM George, P Spagnolo, M Kreuter… - The lancet Respiratory …, 2020 - thelancet.com
Within the spectrum of fibrosing interstitial lung diseases (ILDs) is a subset of patients who
have inexorable progression of pulmonary fibrosis despite treatment, which is known as the …

The lung in rheumatoid arthritis: focus on interstitial lung disease

P Spagnolo, JS Lee, N Sverzellati… - Arthritis & …, 2018 - Wiley Online Library
Interstitial lung disease (ILD) is an increasingly recognized complication of rheumatoid
arthritis (RA) and is associated with significant morbidity and mortality. In addition …

Non‐steroid agents for idiopathic pulmonary fibrosis

P Spagnolo, C Del Giovane, F Luppi… - Cochrane Database …, 1996 - cochranelibrary.com
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) or Usual Interstitial Pneumonia
(UIP) is a form of chronic fibrosing interstitial pneumonia of unknown aetiology, with …

[HTML][HTML] Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

P Spagnolo, O Distler, CJ Ryerson… - Annals of the …, 2021 - ard.bmj.com
Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct
aetiologies, can manifest as a pulmonary complication of an underlying autoimmune and …

Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis

M Kreuter, W Wuyts, E Renzoni, D Koschel… - The Lancet …, 2016 - thelancet.com
Background Gastro-oesophageal reflux disease is a potential risk factor for the development
and progression of idiopathic pulmonary fibrosis (IPF). We aimed to investigate the effect of …

Moving object segmentation by background subtraction and temporal analysis

P Spagnolo, M Leo, A Distante - Image and Vision Computing, 2006 - Elsevier
In this paper, we address the problem of moving object segmentation using background
subtraction. Solving this problem is very important for many applications: visual surveillance …